Cancer pain: where are we now?

被引：49
|
作者：
Magee, David [1 ]
Bachtold, Sabina [1 ]
Brown, Matthew [1 ,2 ]
Farquhar-Smith, Paul [1 ]
机构：
[1] Royal Marsden Hosp, Dept Pain Med, Fulham Rd, London SW3 6JJ, England
[2] Inst Canc Res, Targeted Approaches Canc Pain Grp, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England
来源：
PAIN MANAGEMENT | 2019年 / 9卷 / 01期
关键词：
cancer pain; large-scale data; pain assessment; pain management; recent advances; PERIPHERAL NEUROPATHIC PAIN; INDUCED ORAL MUCOSITIS; PERSISTENT POSTSURGICAL PAIN; INHIBITOR-INDUCED ARTHRALGIA; EARLY PALLIATIVE CARE; QUALITY-OF-LIFE; BREAST-CANCER; RADIATION-THERAPY; DOUBLE-BLIND; NERVE DAMAGE;
D O I：
10.2217/pmt-2018-0031
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Increasing numbers of those living with and beyond cancer presents a clinical challenge for pain specialists. A large proportion of these patients experience pain secondary to their disease or its treatment, impeding rehabilitation and significantly impacting upon their quality of life. The successful management of this pain presents a considerable challenge. This review aims to outline current concepts and treatment options, while considering nuances within pain assessment and the use of large-scale data to help guide further advances.
引用
收藏
页码：63 / 79
页数：17
相关论文
共 50 条
  • [1] Metformin and Breast Cancer: Where Are We Now?
    Cejuela, Monica
    Martin-Castillo, Begona
    Menendez, Javier A.
    Pernas, Sonia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [2] Persistent postoperative pain: where are we now?
    Niraj, G.
    Rowbotham, D. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2011, 107 (01) : 25 - 29
  • [3] Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
    Rodriguez, Isabel V.
    Ghezelayagh, Talayeh
    Pennington, Kathryn P.
    Norquist, Barbara M.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1355 - 1366
  • [4] Personalized treatment of neuropathic pain: Where are we now?
    Bouhassira, Didier
    Attal, Nadine
    EUROPEAN JOURNAL OF PAIN, 2023, 27 (09) : 1084 - 1098
  • [5] Laparoscopic surgery for gastric cancer: where are we now and where are we going?
    Huang, Lei
    Li, Tuan-Jie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1145 - 1157
  • [6] Immunotherapy and Hepatocellular Cancer: Where Are We Now?
    Valery, Marine
    Cervantes, Baptiste
    Samaha, Ramy
    Gelli, Maximiliano
    Smolenschi, Cristina
    Fuerea, Alina
    Tselikas, Lambros
    Klotz-Prieux, Caroline
    Hollebecque, Antoine
    Boige, Valerie
    Ducreux, Michel
    CANCERS, 2022, 14 (18)
  • [7] Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review
    Kent, Collin L.
    McDuff, Susan G. R.
    Salama, Joseph K.
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5954 - 5968
  • [8] Treatment for small cell lung cancer, where are we now?-a review
    Alvarado-Luna, Gabriela
    Morales-Espinosa, Daniela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 26 - 38
  • [9] Regulatory T cells in cancer: where are we now?
    Gallimore, Awen
    Quezada, Sergio A.
    Roychoudhuri, Rahul
    IMMUNOLOGY, 2019, 157 (03) : 187 - 189
  • [10] Ethnicity and breast cancer in the UK: Where are we now?
    Gathani, Toral
    Chaudhry, Anushka
    Chagla, Leena
    Chopra, Sharat
    Copson, Ellen
    Purushotham, Arnie
    Vidya, Raghavan
    Cutress, Ramsey
    EJSO, 2021, 47 (12): : 2978 - 2981
12345